Outcomes of a High-Volume Organ Procurement Organization in the Era of Increasing Donation After Circulatory Death
Related Experiment Video
Updated: Aug 29, 2025

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
Mark J Hobeika1,2,3, Terri Menser1,2,3,4, Kevin Myer5
1J.C. Walter, Jr. Transplant Center and Department of Surgery, 23530Houston Methodist, Houston, TX, USA.
Insights
Donation after circulatory death (DCD) organ utilization can be improved by standardizing processes and policies. Factors like pre-mortem heparin and shorter warm ischemia times enhance DCD organ transplantation success.
Area of Science:
- Organ transplantation research
- Public health policy
- Medical process evaluation
Background:
- Donation after circulatory death (DCD) is a growing organ donation pathway in the US.
- Comprehensive data on the DCD referral to transplantation process is limited.
- Understanding donor type differences is crucial for optimizing organ utilization.
Purpose of the Study:
- To quantify differences in the donation pathway stages by donor type.
- To identify factors associated with successful DCD organ utilization.
- To examine the role of first-person authorization in DCD.
Main Methods:
- Program evaluation of data from a single organ procurement organization in 2018.
- Analysis of demographic and clinical predictors of donation process progression.
- Logistic regression models to assess predictors of utilization and authorization.
Main Results:
- Differences in authorization rates were observed between DCD and donation after brainstem death (DBD) donors, influenced by age, race, and ethnicity.
- Next-of-kin refusal occurred in 23% of first-person authorized DCD cases.
- Pre-mortem heparin administration, donor age, and warm ischemia time <30 min predicted DCD organ utilization.
Conclusions:
- Findings offer strategies to increase DCD organ authorization and transplantation rates.
- Identified areas for process standardization and policy development in DCD donation.
- Highlights the importance of donor registration and authorization in DCD.
Abstract:
Introduction: Donation after circulatory death (DCD) is rapidly increasing in the United States. Detailed data outlining the process from referral to organ transplantation is lacking. Project Aims: We sought to quantify differences at each stage along the referral to donation pathway by donor type. Additionally, we examined factors associated with successful DCD organ utilization. Design: This program evaluation analyzed data from a single organ procurement organization in 2018 to assess demographic and clinical predictors of progression through the donation process, including the role of first-person authorization in DCD. Descriptive statistics were examined by donation stage for demographic characteristics using chi-square; univariate and multivariate logistic regression was used to model predictors of utilization and authorization by organ type, respectively. Results: There were 2466 organ donation referrals during 2018, including 575 donations after brainstem death (DBD), 1890 controlled DCD referrals, and 1 uncontrolled DCD referral. Univariate and multivariate logistic regression models highlighted differences in authorization rates by donor type (DCD vs DBD) and by age, race, and ethnicity. Next-of-kin authorization was declined in 23% of first-person authorized potential DCD, highlighting issues related to the role of donor registration in DCD. Pre-mortem heparin administration was predictive of DCD organ utilization; donor age and warm ischemia time of less than 30 min was statistically significantly associated with DCD extra-renal organ utilization. Conclusion: These results provided insight into strategies for increasing authorization and transplantation of organs from DCD donors and identified areas of improvement for process standardization and policy development.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure

